D. E. Shaw Research is a New York‑based R&D organization with 100–200 employees generating revenue between $50 million and $100 million.
Its core expertise spans drug discovery, computational chemistry, machine learning, molecular dynamics simulation, biochemistry, scientific computing, drug‑discovery software tools, parallel computing, protein folding, force‑field development, ASIC design, numerical analysis, and special‑purpose computing architectures.
The leadership team includes Jodi Hezky (Head of Business Development), Madeleine Weingarten (Head of ML Data), Pelin Ayaz (Head of Target Biology Research), Julie Baher Driansky (Head of Operations), Fabrizio Giordanetto (Head of Research and Development), Henri Palacci (Research Engineer – Technical Staff), Vinicius de Freitas Reis (Technical Staff), Jennifer Koenitzer (Drug Discovery, Pharmacology, Biology & Translational Research), Jack Terrett (Medicinal Chemistry), Ray Wang (Research Scientist), Andreas Tosstorff (Scientist), Mihail Bogojeski (Machine Learning Researcher), Leon Klein (Machine Learning Researcher), Chris O’Brien (Senior Research Scientist), Shaggu Manbhaggu (Drug Discovery Software Engineer), and Hyeongu Yun (Technical Staff).